Clifton R. LaDuane 4
4 · KEMPHARM, INC · Filed Jan 13, 2023
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Clifton R. LaDuane
Other
Transactions
- Purchase
Common Stock
2023-01-13$5.58/sh+25$140→ 9,277 total - Purchase
Common Stock
2023-01-13$5.82/sh+610$3,550→ 9,252 total